These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 15788477)

  • 1. Role of mammalian target of rapamycin signaling in compensatory renal hypertrophy.
    Chen JK; Chen J; Neilson EG; Harris RC
    J Am Soc Nephrol; 2005 May; 16(5):1384-91. PubMed ID: 15788477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy.
    Kemi OJ; Ceci M; Wisloff U; Grimaldi S; Gallo P; Smith GL; Condorelli G; Ellingsen O
    J Cell Physiol; 2008 Feb; 214(2):316-21. PubMed ID: 17941081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways.
    Liu L; Li F; Cardelli JA; Martin KA; Blenis J; Huang S
    Oncogene; 2006 Nov; 25(53):7029-40. PubMed ID: 16715128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S6 kinase 1 knockout inhibits uninephrectomy- or diabetes-induced renal hypertrophy.
    Chen JK; Chen J; Thomas G; Kozma SC; Harris RC
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F585-93. PubMed ID: 19474189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in mammalian target of rapamycin signaling pathways after traumatic brain injury.
    Chen S; Atkins CM; Liu CL; Alonso OF; Dietrich WD; Hu BR
    J Cereb Blood Flow Metab; 2007 May; 27(5):939-49. PubMed ID: 16955078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mTOR signaling pathway mediates control of ribosomal protein mRNA translation in rat liver.
    Reiter AK; Anthony TG; Anthony JC; Jefferson LS; Kimball SR
    Int J Biochem Cell Biol; 2004 Nov; 36(11):2169-79. PubMed ID: 15313464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling pathways initiated by beta-hydroxy-beta-methylbutyrate to attenuate the depression of protein synthesis in skeletal muscle in response to cachectic stimuli.
    Eley HL; Russell ST; Baxter JH; Mukerji P; Tisdale MJ
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E923-31. PubMed ID: 17609254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetaldehyde promotes rapamycin-dependent activation of p70(S6K) and glucose uptake despite inhibition of Akt and mTOR in dopaminergic SH-SY5Y human neuroblastoma cells.
    Fang CX; Yang X; Sreejayan N; Ren J
    Exp Neurol; 2007 Jan; 203(1):196-204. PubMed ID: 16962100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raptor-rictor axis in TGFbeta-induced protein synthesis.
    Das F; Ghosh-Choudhury N; Mahimainathan L; Venkatesan B; Feliers D; Riley DJ; Kasinath BS; Choudhury GG
    Cell Signal; 2008 Feb; 20(2):409-23. PubMed ID: 18068336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of mTOR signaling with rapamycin attenuates renal hypertrophy in the early diabetic mice.
    Sakaguchi M; Isono M; Isshiki K; Sugimoto T; Koya D; Kashiwagi A
    Biochem Biophys Res Commun; 2006 Feb; 340(1):296-301. PubMed ID: 16364254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the phosphorylation and integrity of protein synthesis initiation factor eIF4GI and the translational repressor 4E-BP1 by p53.
    Constantinou C; Clemens MJ
    Oncogene; 2005 Jul; 24(30):4839-50. PubMed ID: 15897901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheb activation of mTOR and S6K1 signaling.
    Hanrahan J; Blenis J
    Methods Enzymol; 2006; 407():542-55. PubMed ID: 16757352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of EGF receptor activation in angiotensin II-induced renal epithelial cell hypertrophy.
    Chen J; Chen JK; Neilson EG; Harris RC
    J Am Soc Nephrol; 2006 Jun; 17(6):1615-23. PubMed ID: 16641152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clofibrate treatment promotes branched-chain amino acid catabolism and decreases the phosphorylation state of mTOR, eIF4E-BP1, and S6K1 in rat liver.
    Ishiguro H; Katano Y; Nakano I; Ishigami M; Hayashi K; Honda T; Goto H; Bajotto G; Maeda K; Shimomura Y
    Life Sci; 2006 Jul; 79(8):737-43. PubMed ID: 16616211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of ribosomal protein S6 mediates compensatory renal hypertrophy.
    Xu J; Chen J; Dong Z; Meyuhas O; Chen JK
    Kidney Int; 2015 Mar; 87(3):543-56. PubMed ID: 25229342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2.
    Le Bacquer O; Petroulakis E; Paglialunga S; Poulin F; Richard D; Cianflone K; Sonenberg N
    J Clin Invest; 2007 Feb; 117(2):387-96. PubMed ID: 17273556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meal feeding enhances formation of eIF4F in skeletal muscle: role of increased eIF4E availability and eIF4G phosphorylation.
    Vary TC; Lynch CJ
    Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E631-42. PubMed ID: 16263769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-induced hypomyelination in the developing brain is mammalian target of rapamycin-4E-binding protein-1 signaling dependent.
    Bilali F; Kumar P; Feerick J; Berezin S; Farahani R
    Neuroreport; 2008 Apr; 19(6):635-9. PubMed ID: 18382277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism by which mammalian target of rapamycin inhibitors sensitize multiple myeloma cells to dexamethasone-induced apoptosis.
    Yan H; Frost P; Shi Y; Hoang B; Sharma S; Fisher M; Gera J; Lichtenstein A
    Cancer Res; 2006 Feb; 66(4):2305-13. PubMed ID: 16489035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis.
    Gao XM; Wong G; Wang B; Kiriazis H; Moore XL; Su YD; Dart A; Du XJ
    J Hypertens; 2006 Aug; 24(8):1663-70. PubMed ID: 16877971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.